JPS57203098A - Salt products of cholic acids, manufacture and therapeutical composition containing same as effective component - Google Patents

Salt products of cholic acids, manufacture and therapeutical composition containing same as effective component

Info

Publication number
JPS57203098A
JPS57203098A JP57085079A JP8507982A JPS57203098A JP S57203098 A JPS57203098 A JP S57203098A JP 57085079 A JP57085079 A JP 57085079A JP 8507982 A JP8507982 A JP 8507982A JP S57203098 A JPS57203098 A JP S57203098A
Authority
JP
Japan
Prior art keywords
manufacture
composition containing
effective component
cholic acids
containing same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP57085079A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6312478B2 (enExample
Inventor
Bonarudei Antonio
Morinari Ejideio
Supuringoro Banna
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Erregierre Industria Chimica SpA
Original Assignee
Erregierre Industria Chimica SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erregierre Industria Chimica SpA filed Critical Erregierre Industria Chimica SpA
Publication of JPS57203098A publication Critical patent/JPS57203098A/ja
Publication of JPS6312478B2 publication Critical patent/JPS6312478B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
JP57085079A 1981-05-21 1982-05-21 Salt products of cholic acids, manufacture and therapeutical composition containing same as effective component Granted JPS57203098A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT21867/81A IT1136624B (it) 1981-05-21 1981-05-21 Prodotti di salificazione di acidi colici,processo per la loro preparazione e composizioni terapeutiche che li comprendono come principio attivo

Publications (2)

Publication Number Publication Date
JPS57203098A true JPS57203098A (en) 1982-12-13
JPS6312478B2 JPS6312478B2 (enExample) 1988-03-18

Family

ID=11187975

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57085079A Granted JPS57203098A (en) 1981-05-21 1982-05-21 Salt products of cholic acids, manufacture and therapeutical composition containing same as effective component

Country Status (13)

Country Link
US (1) US4404199A (enExample)
EP (1) EP0065666B1 (enExample)
JP (1) JPS57203098A (enExample)
AT (1) ATE11528T1 (enExample)
CA (1) CA1194469A (enExample)
DE (1) DE3262109D1 (enExample)
DK (1) DK159456C (enExample)
ES (1) ES512391A0 (enExample)
IE (1) IE52917B1 (enExample)
IT (1) IT1136624B (enExample)
NO (1) NO158423C (enExample)
PT (1) PT74864B (enExample)
YU (1) YU43516B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1152801B (it) * 1982-08-17 1987-01-14 Proter Spa Composti steroidei ad attivita' coleretica, processo per la loro preparazione e composizioni terapeutiche che li contengono come principio attivo
US5753269A (en) * 1995-12-27 1998-05-19 Bayer Corporation Otic microbial combinations
IL139241A0 (en) * 1998-05-13 2001-11-25 Novo Nordisk As Meiosis regulating compounds
US20020119921A1 (en) * 1999-03-31 2002-08-29 Michael Streit Thrombospondin-2 and uses thereof
US6692738B2 (en) * 2000-01-27 2004-02-17 The General Hospital Corporation Delivery of therapeutic biologicals from implantable tissue matrices
BR112017001623B1 (pt) * 2014-07-29 2022-11-29 Shenzhen Hightide Biopharmaceutical, Ltd Sal de adição ácido-base em uma forma substancialmente pura, composição farmacêutica compreendendo uma quantidade do referido sal e seus usos

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS50116619A (enExample) * 1973-12-03 1975-09-12
JPS5529075A (en) * 1978-08-24 1980-03-01 Suzuki Motor Co Ltd Crank room oil recoverer for 2-cycle engine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2369M (fr) * 1962-10-17 1964-03-02 Jouveinal Lab Nouveau médicament contre les troubles du systeme nerveux central.
GB1532413A (en) * 1974-12-23 1978-11-15 Union International Co Ltd Chenodeoxycholic acid
FR2358144A1 (fr) * 1976-07-13 1978-02-10 Lipha Nouvelle composition medicamenteuse pour le traitement de la lithiase biliaire
US4186143A (en) * 1977-06-20 1980-01-29 Canada Packers Limited Chenodeoxycholic acid recovery process
US4241047A (en) * 1979-07-18 1980-12-23 Lipha, Lyonnaise Industrielle Pharmaceutique Novel medicinal composition for the treatment of biliary lithiasis

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS50116619A (enExample) * 1973-12-03 1975-09-12
JPS5529075A (en) * 1978-08-24 1980-03-01 Suzuki Motor Co Ltd Crank room oil recoverer for 2-cycle engine

Also Published As

Publication number Publication date
ES8302735A1 (es) 1983-02-01
NO158423C (no) 1988-09-14
PT74864B (fr) 1983-12-07
IE52917B1 (en) 1988-04-13
NO158423B (no) 1988-05-30
US4404199A (en) 1983-09-13
CA1194469A (en) 1985-10-01
IE821056L (en) 1982-11-21
DK159456C (da) 1991-03-18
ES512391A0 (es) 1983-02-01
ATE11528T1 (de) 1985-02-15
IT1136624B (it) 1986-09-03
YU43516B (en) 1989-08-31
JPS6312478B2 (enExample) 1988-03-18
DE3262109D1 (en) 1985-03-14
PT74864A (fr) 1982-06-01
NO821672L (no) 1982-11-22
YU106582A (en) 1984-10-31
EP0065666B1 (en) 1985-01-30
DK159456B (da) 1990-10-15
EP0065666A1 (en) 1982-12-01
IT8121867A0 (it) 1981-05-21
DK226882A (da) 1982-11-22

Similar Documents

Publication Publication Date Title
IL90804A0 (en) Diphosphonic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing them
DE3060592D1 (en) Derivatives of 2,4,6-triodo-isophthalic acid, process for their preparation and x-ray contrast agents containing them
DE3370626D1 (en) Imidazolylalkylthienyl-tetrahydropyridazines and process for their preparation
HUT51138A (en) Process for production of medical composition against osteoporosis containing derivatives of imidasole /1,2-a/-piridasine or pirasine
DE3465590D1 (en) Hydroxamic acids, their preparation and their use in pharmaceutical compositions
JPS57203098A (en) Salt products of cholic acids, manufacture and therapeutical composition containing same as effective component
EP0249248A3 (en) Purine derivatives
IL70160A0 (en) 6alpha-methylcorticoids,processes for their preparation and pharmaceutical compositions containing them
DE3061333D1 (en) Process for the preparation of gastric acid neutralizing agents and gastric acid neutralizing agents
PT76196A (fr) Procede de preparation de derives d'imidazolidine et de compositions pharmaceutiques les contenant
IE820594L (en) Carnitine esters
IL87246A0 (en) Process for the manufacture of novel unsaturated amino phosphonic acid compounds
DE3467705D1 (en) Use of 4,5'-azo-bis-salicylic acid for the manufacture of a medicament for the treatment of inflammatory disorders in the intestine
DE3568164D1 (en) Pyridine derivatives, processes for their preparation and pharmaceutical compositions containing them
YU199985A (en) Process for preparation of n-substituted derivatives of azyridine -2-carboxylic acids
JPS57167958A (en) Salt of 5-fluoro-2-methyl-1-(p- (methylsulfinyl)benzylidene)indene-3-acetic acid
EP0320727A3 (en) Process for the preparation of cysteamine acid addition salts
ES8103760A1 (es) Procedimiento de preparacion de (20 s) - 3 - - ((aminoace- til)amino)-5 - - pregnan- 20 - ol
ZA761709B (en) Process for the preparation of the o,o-dimethyl-o-(2,2-dichlorovinyl) ester or the o,o-diethyl-o-(2,2-cichlorovinyl) ester of thionophosphoric acid
ES473070A1 (es) Procedimiento para la obtencion de 2,3,4,7,8.9-octahidropi- razinopirimidinonas substituidas
HRP940444A2 (en) Process for the preparation of unsaturated amino acid compounds
JPS57183798A (en) N-p-carbamoylphenyl-d-xylopyranosylamine
IT1269823B (it) Difosfonati e loro impiego farmacologico nel trattamento dell'osteoporosi